David J Schlanger bought $2.2M of PGNY
Executive Chairman at Progyny, Inc.. 150,000 shares at an average of $14.68, traded Dec 26, 2024, filed Dec 26, 2024.
Score components
- +20RoleChair
- +25Trade size$2.2M at market
- +10Relative to holdingsHoldings up 192%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +50.2%, 3m +51.7%, 6m +45.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001551306-24-000217, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 26, 2024 | POpen-market purchase Common Stock | +150,000 | $14.68 | $2.2M | 228,269 | Dec 26, 2024 |
Related signals
Other insiders at Progyny, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | Progyny, Inc. | Allison Swartz EVP, GC | $102k 3,903 shares | -5% | |
| 42Moderate | Progyny, Inc. | Kevin K Gordon director | $312k 11,500 shares | -63% | |
| 42Moderate | Progyny, Inc. | Kevin K Gordon director | $321k 11,500 shares | -63% | |
| 8Weak | Progyny, Inc. | Melissa B Cummings Chief Operating Officer | $71k 2,244 shares | -3% | |
| 25Weak | Progyny, Inc. | Mark S. Livingston CHIEF FINANCIAL OFFICER | $64k 2,517 shares | -3% | |
| 16Weak | Progyny, Inc. | Allison Swartz EVP, GC | $45k 1,798 shares | -2% | |
| 21Weak | Progyny, Inc. | Geoffrey Clapp Chief Product Officer | $39k 1,530 shares | -3% | |
| 17Weak | Progyny, Inc. | Mark S. Livingston CHIEF FINANCIAL OFFICER | $7,310 279 shares | -0% | |
| 37Weak | Progyny, Inc. | Cheryl Scott director | $196k 7,439 shares | -27% | |
| 17Weak | Progyny, Inc. | Allison Swartz EVP, GC | $61k 2,398 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.